BRIEF published on 02/03/2026 at 07:05, 7 months 13 days ago Sartorius Stedim Biotech records strong growth in 2025 EBITDA Biotechnology Sartorius Growth 2025 Consumables
PRESS RELEASE published on 02/03/2026 at 07:00, 7 months 13 days ago Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026 Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
BRIEF published on 02/02/2026 at 14:01, 7 months 14 days ago Statement of Share Capital of Sartorius Stedim Biotech SA as of January 31, 2026 Share Capital Voting Rights AMF Aubagne Sartorius Stedim
BRIEF published on 02/02/2026 at 14:01, 7 months 14 days ago Sartorius Stedim Biotech Discloses Share and Voting Rights Structure Voting Rights Sartorius Stedim Biotech Regulatory Disclosure Issued Capital Share Structure
PRESS RELEASE published on 02/02/2026 at 13:57, 7 months 14 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. declares the number of shares and voting rights. Details include total shares, theoretical voting rights, and net voting rights Voting Rights Capital Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 02/02/2026 at 13:56, 7 months 14 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital, as of Jan 31, 2026 Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Issued Capital
BRIEF published on 01/06/2026 at 10:28, 8 months 10 days ago Sartorius Stedim Biotech: Half-Year Liquidity Statement Liquidity Contract Kepler Cheuvreux Market Practice Biotech Industry Sartorius Stedim Biotech
BRIEF published on 01/06/2026 at 10:28, 8 months 10 days ago Sartorius Stedim Biotech Liquidity Contract Review Liquidity Contract Transactions Kepler Cheuvreux Sartorius Stedim Biotech Financial Resources
PRESS RELEASE published on 01/06/2026 at 10:23, 8 months 10 days ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech SA releases half-year liquidity contract statement revealing resources on the liquidity account for 2025 and 2026, highlighting share numbers and executed volumes Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech Executions
BRIEF published on 01/05/2026 at 14:55, 8 months 11 days ago Sartorius Stedim Biotech Issues Capital Structure Update Voting Rights Shares Sartorius Stedim Biotech Issued Capital 2025 Update
Published on 09/16/2026 at 23:45, 6 hours 26 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 8 hours 41 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 13 hours 16 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 15 hours 11 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 16 hours 11 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 1 hour 46 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 6 hours 26 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 7 hours 37 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 8 hours 56 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 9 hours 43 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 12 hours 26 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 23 hours 11 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 12 hours ago Report on the Combined General Meeting of the 10th of September 2026
